Zobrazeno 1 - 10
of 83
pro vyhledávání: ''
Autor:
Alla Berlin, Leora Brazg Ferro, Ester Osher, Orit Gutfeld, Inbal Golomb, Inna Ospovat, Viacheslav Soyfer, Ido Wolf, Shira Peleg Hasson
Publikováno v:
Oncology. 99:373-379
Introduction: Extrapulmonary small-cell cancer (EPSCC) is a relatively rare malignancy. The management of EPSCC is usually extrapolated from small-cell lung cancer (SCLC). In spite of the morphological similarity of the 2 malignancies, there are many
Autor:
Kazuhiro Kitajima, Hirotoshi Ishigaki, Takashi Yokoi, Ryo Takahashi, Hiroshi Doi, Toshiyuki Minami, Akifumi Nakamura, Yasuhiro Nakajima, Takashi Kijima, Yuichi Koda, Kozo Kuribayashi
Publikováno v:
Oncology. 99:161-168
Background: Cisplatin-pemetrexed combination chemotherapy is the current standard primary treatment for malignant pleural mesothelioma (MPM). It was first approved for untreated and unresectable MPM in the 2003 National Comprehensive Cancer Network (
Publikováno v:
Oncology. 99:105-113
Introduction: Cisplatin (CDDP)-induced nephrotoxicity is a concern in CDDP-based chemotherapy. The goal of this multicenter retrospective study was to identify potential risk factors for CDDP nephrotoxicity. Methods: Clinical data were reviewed for 7
Autor:
Masahiro Noda, Takaaki Arigami, Hiroshi Kurahara, Daisuke Matsushita, Satoshi Iino, Keishi Okubo, Yoshiaki Kita, Yoshikazu Uenosono, Yota Kawasaki, Shigehiro Yanagita, Sumiya Ishigami, Kosei Maemura, Shinichiro Mori, Ken Sasaki, Shoji Natsugoe
Publikováno v:
Oncology. 98:273-279
Objective: Chemotherapy is generally recommended as the first-line standard treatment in patients with liver metastasis from gastric cancer. However, the clinical impact of surgical treatment remains unclear in responders after chemotherapy. The pres
Autor:
Kausar Suleman, Noha Jastaniyah, Tusneem Elhassan, Wafa Alkhayal, Osama Almalik, Ali Hassan Mushtaq, Adher Al-Sayed, Dahish Ajarim, Emaan Haque, Taher Al-Tweigeri, Ahmed Badran
Publikováno v:
Oncology. 98:168-173
Background:There is a paucity of literature examining the impact of timing of surgery after neoadjuvant chemotherapy. Objective:This study aimed to analyze the impact of the time taken to initiate surgical treatment following completion of neoadjuvan
Autor:
Xuejiao Wang, Jinghua Xia, Tao Jiang, Lei Wang, Ying Ying Sun, Zhipei Zhang, Yanning Zhang, Lijun Huang, Miaomiao Wen, Sanhu Yang
Publikováno v:
Oncology Research and Treatment. 43:686-693
Background: Some non-small-cell lung cancer (NSCLC) patients are unexpectedly diagnosed with stage IIIA-N2 disease at the time of thoracoscopy or thoracotomy. Because of the limited statistical evidence of induction chemotherapy for these patients, i
Autor:
Yoshikazu Uenosono, Daisuke Matsushita, Yoshiaki Kita, Shigehiro Yanagita, Shoji Natsugoe, Hiroshi Kurahara, Masahiro Noda, Ken Sasaki, Sumiya Ishigami, Keishi Okubo, Takaaki Arigami, Takao Ohtsuka, Shinichiro Mori
Publikováno v:
Oncology. 98:798-806
Objective: Although chemotherapy has been clinically recommended as the initial treatment for patients with peritoneal dissemination of gastric cancer, poor prognosis has been noted among the same patients. However, the prognostic significance of con
Autor:
Yoshitaka Inaba, Yasuaki Arai, Kiyoshi Matsueda, Hideyuki Nishiofuku, Takeshi Aramaki, Yozo Sato, Toshihiro Tanaka, Miyuki Sone, Masaya Miyazaki, Yoshitaka Morita
Publikováno v:
Oncology. 98:267-272
Introduction: Hepatic arterial infusion chemotherapy (HAIC) is a feasible treatment for patients with colorectal cancer (CRC) with unresectable liver metastases. Objective: The aim of this retrospective study was to assess HAIC of 5-fluorouracil (5FU
Autor:
Chia Che Wu, Meng Che Hsieh, Cheng-Hua Huang, Shih Yu Huang, Harvey Yu-Li Su, Po Hui Chiang, Chun-Chieh Huang, Kun Ming Rau, Jui Ming Liu, Hao Lun Luo, Ming Tse Sung
Publikováno v:
Oncology. 98:146-153
Objectives: Platinum-based chemotherapy is the standard treatment for metastatic urothelial carcinoma (mUC). However, considering elderly patients often experience comorbidities and frailty, the utility of cisplatin-based chemotherapy for elderly pat
Autor:
Francesca Platini, Alba Bianco, Carlo Resteghini, Donata Galbiati, Massimo Milione, Cristiana Bergamini, Paolo Bossi, Lisa Licitra, Salvatore Alfieri, Stefano Cavalieri, Federica Perrone, Laura D. Locati
Publikováno v:
Oncology. 97:112-118
Background: Recurrent or metastatic (R/M) skin squamous cell carcinoma (sSCC) not amenable of surgery or irradiation may benefit from systemic therapies. Epidermal growth factor receptor (EGFR) inhibitors and, more recently, immune checkpoint blocker